Deep Tech Startups

SiFive develops processor IP based on the open-standard RISC-V instruction set architecture, offering customizable and scalable chip designs. It serves semiconductor and hardware developers building processors across a range of applications.

9 investors

SkyFi operates a platform that provides access to satellite imagery and Earth observation analytics from multiple providers through a single, user-friendly interface with transparent pricing. The platform serves commercial and government sectors across various industries needing geospatial insights for decision-making.

9 investors

Skyloom builds space-based optical communication systems that provide high-capacity data relay between satellites and from satellites to Earth in low Earth orbit. It serves businesses and governments operating satellite constellations for observation and communication applications, engineering its services in-house.

9 investors

Smack builds domain-specific AI models for military decision-making. The company serves defense and military organizations across branches including the Air Force, Navy, Marines, and Special Operations Command.

9 investors

Sofar operates an ocean monitoring network and analytics platform serving maritime shipping companies and marine researchers. The company operates Spotter, a network of ocean sensors for data collection, and Wayfinder, a voyage optimization platform that helps shipping companies reduce fuel consumption and emissions by 4-9%.

9 investors

Softmax builds AI systems based on organic alignment principles—the concept that agents remaining aligned with human values also maintain alignment with each other. The team conducts research spanning AI safety, multi-agent frameworks, and governance methods.

9 investors

Spore.Bio develops real-time microbial detection technology for industrial quality control, replacing traditional Petri dish culture methods used in factory settings. It combines photonics, AI, and biology to detect, quantify, and identify living microorganisms without reagents or culturing.

9 investors

Svante builds filters and modular rotary contactor machines that capture and remove CO2 from industrial emissions and directly from the air. The company (formerly Inventys Inc.) serves heavy-emitting industries such as cement, oil, and energy with carbon capture and removal technology, including its proprietary metal organic framework (MOF) sorbent.

9 investors

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline. The company serves patients with motor impairment and cognitive decline using a minimally invasive approach inspired by cardiac interventional procedures.

9 investors

Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines. It develops therapeutic candidates by integrating high-throughput experimentation with machine learning.

9 investors

Thea Energy develops fusion energy systems based on a stellarator architecture that replaces complex 3D magnet coils with arrays of mass-manufacturable planar magnets controlled by software. Its first system, Eos, is a neutron source stellarator intended to demonstrate fusion performance and de-risk its planned fusion power plant, Helios.

9 investors

Turbine develops computational simulations of cells to accelerate drug discovery and development in oncology, using in silico predictions validated through wet lab experiments.

9 investors

Ubiquity6 develops multiplayer technology and infrastructure for shared, collaborative experiences. The company was acquired by Discord.

9 investors

Untap Health builds wastewater monitoring technology that detects pathogens such as COVID-19, influenza, RSV, and norovirus in real-time, flagging health risks before symptoms appear. It serves organisations including offices, universities, schools, hospitals, care homes, hotels, and airports to help contain the spread of illness.

9 investors

Vaire develops reversible computing hardware to improve energy efficiency and compute performance beyond the constraints of Moore's law. The company targets machine intelligence applications in AI and defense sectors.

9 investors

X-Therma develops a proprietary peptoid-based technology that inhibits ice crystal formation to enable long-term sub-zero preservation and transport of cells, tissues, organs, and other biologics. Its products, including the XT-ViVo preservation solution and TimeSeal organ transport device, target organ and biologic preservation for transplantation.

9 investors

Yoneda Labs applies AI/ML and high-throughput experimentation (HTE) to chemical reaction optimization, including cross-coupling reactions, for the life sciences and pharmaceutical research market. The company combines chemistry research, software, and robotics to optimize synthetic reactions.

9 investors

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities. The platform leverages AI and high-resolution data to compress timelines in drug development.

9 investors

Axelspace manufactures microsatellites using onsite cleanroom facilities and develops commercial applications for satellite technology. The company serves the space industry and related sectors requiring Earth observation and communications capabilities.

9 investors

Occam Razor develops drug discovery technology using digital science to target neurodegenerative diseases, focusing initially on Parkinson's disease and brain aging.

8 investors

10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.

8 investors

An AI-native biotech company that combines multimodal data, AI models, and high-throughput lab automation to discover small and large molecule therapeutics. Its infrastructure supports AI-enabled drug discovery across multiple therapeutic modalities.

8 investors

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling. It serves pharmaceutical and life-science researchers as an alternative to animal studies and Caco-2 cell lines, offering ready-to-use kits and custom studies.

8 investors

ALTR builds alcohol separation technology, including its Velvet Blade precision system, that lets beverage makers reduce the alcohol content of drinks such as wine while preserving flavor and sensory qualities. The company serves beverage producers looking to create lower-alcohol products.

8 investors